Gossamer Bio, Inc. (GOSS) Form SCHEDULE 13D/A — Oct 8, 2026
The D. E. Shaw group filed Amendment No. 5 to its Schedule 13D on Gossamer Bio to correct Amendment No.
Key figures
- Shares Outstanding
- 6116391
- Cogence shares
- 14190
- Valence shares
- 358693
- Cogence percent
- 0.2%
- Valence percent
- 5.9%
- Special meeting date
- 2026-10-27
- Percent of class DESCO
- 6%
- Shared dispositive power
- 289551
- Aggregate beneficial ownership DESCO LP
- 369459
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.